Moderna's stock gains as it announces authorization for its COVID-19 shot in India
Dow Jones2021-06-29
MW Moderna's stock gains as it announces authorization for its COVID-19 shot in India
Shares of Moderna Inc. $(MRNA)$ gained 6.3% in trading on Tuesday after the company said its COVID-19 vaccine has been authorized for adults in India. Moderna's shot has already been authorized in more than 50 countries, including the U.S. Moderna's stock is up 118.5% this year, while the broader S&P 500 has gained 14.2%.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments